Literature DB >> 8797684

Stool viruses, coinfections, and diarrhea in HIV-infected patients. Berlin Diarrhea/Wasting Syndrome Study Group.

W Schmidt1, T Schneider, W Heise, T Weinke, H J pple, M Stöffler-Meilicke, O Liesenfeld, R Ignatius, M Zeitz, E O Riecken, R Ullrich.   

Abstract

To examine the prevalence of stool viruses and their role in the pathogenesis of diarrhea in HIV infection, we evaluated biopsies and repeated stool samples of 256 HIV-infected patients undergoing diagnostic endoscopy because of diarrhea (n = 136) or other symptoms (n = 120) for bacterial, protozoal, and viral enteropathogens. In 70% of the patients with diarrhea, at least one potential enteropathogen was detected. Stool virus was detected by electron microscopy in 17% (44 of 256), adenovirus in 6.6% (17 of 256), and coronavirus in 11.3% (29 of 256) of the patients. Adenovirus and coronavirus were detected more frequently in patients with diarrhea than in patients without diarrhea [adenovirus 10% (13 of 136) vs. 3.3% (4 of 120), p = 0.0129; coronavirus 15% (21 of 136) vs. 6.6% (8 of 120), p = 0.0142]. Sixty-one percent of patients harboring stool virus were coinfected by another enteropathogen. Pathogens other than stool virus were detected more frequently in patients harboring adenovirus (82%) than in patients without stool virus (48%, p < 0.025). Adenovirus and coronavirus are frequently detected in stools of HIV- infected patients and may contribute to diarrhea. Adenovirus infection may facilitate the occurrence of other intestinal pathogens. Due to frequent coinfections, detection of stool viruses reduces the rate of diarrhea of unknown origin only by approximately 5%.

Entities:  

Mesh:

Year:  1996        PMID: 8797684     DOI: 10.1097/00042560-199609000-00006

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  12 in total

Review 1.  Immunopathology of human immunodeficiency virus infection in the gastrointestinal tract.

Authors:  T Schneider; R Ullrich; M Zeitz
Journal:  Springer Semin Immunopathol       Date:  1997

2.  Frequent detection of human adenovirus from the lower gastrointestinal tract in men who have sex with men.

Authors:  Marcel E Curlin; Meei-Li Huang; Xiaoyan Lu; Connie L Celum; Jorge Sanchez; Stacy Selke; Jared M Baeten; Richard A Zuckerman; Dean D Erdman; Lawrence Corey
Journal:  PLoS One       Date:  2010-06-25       Impact factor: 3.240

3.  Enteric viral infections as a cause of diarrhoea in the acquired immunodeficiency syndrome.

Authors:  P D Thomas; R C Pollok; B G Gazzard
Journal:  HIV Med       Date:  1999-10       Impact factor: 3.180

Review 4.  Enteric viruses in HIV-related diarrhoea.

Authors:  R C Pollok; M J Farthing
Journal:  Mol Med Today       Date:  2000-12

Review 5.  Small intestine pathogens in AIDS: conventional and opportunistic.

Authors:  J Koch; R L Owen
Journal:  Gastrointest Endosc Clin N Am       Date:  1998-10

Review 6.  Diagnosis and treatment of colonic disease in AIDS.

Authors:  K E Mönkemüller; C M Wilcox
Journal:  Gastrointest Endosc Clin N Am       Date:  1998-10

Review 7.  Review article: the therapy of gastrointestinal infections associated with the acquired immunodeficiency syndrome.

Authors:  C M Wilcox; K E Mönkemüller
Journal:  Aliment Pharmacol Ther       Date:  1997-06       Impact factor: 8.171

8.  Ordinary and opportunistic enteropathogens associated with diarrhea in Senegalese adults in relation to human immunodeficiency virus serostatus.

Authors:  A Gassama; P S Sow; F Fall; P Camara; A Guèye-N'diaye; R Seng; B Samb; S M'Boup; A Aïdara-Kane
Journal:  Int J Infect Dis       Date:  2001       Impact factor: 3.623

9.  Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection.

Authors:  Wai K Leung; Ka-Fai To; Paul K S Chan; Henry L Y Chan; Alan K L Wu; Nelson Lee; Kwok Y Yuen; Joseph J Y Sung
Journal:  Gastroenterology       Date:  2003-10       Impact factor: 22.682

Review 10.  Features of enteric disease from human coronaviruses: Implications for COVID-19.

Authors:  Nevio Cimolai
Journal:  J Med Virol       Date:  2020-06-05       Impact factor: 20.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.